Icosavax Stock

icosavax.comHealthcare / BioTech & PharmaFounded: 2017

Icosavax develops safe and effective vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Icosavax before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Icosavax before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Icosavax’s Stock

plusminus
Can you buy Icosavax’s stock?
You can no longer buy Icosavax’s stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Icosavax’s stock?
You can no longer sell stock of Icosavax on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus
What is Icosavax’s stock price?
The stock price of Icosavax is $15.58 as of 1/18/24.
plusminus
What is Icosavax’s stock ticker symbol?
The ticker symbol of Icosavax is ICVX.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 16, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.